Item | Benign lesions | Malignant lesions | P value | |
---|---|---|---|---|
Primary site | Early SUV | 6.95 ± 2.1 | 7.7 ± 3.7 | 1.0 |
Late SUV | 2.9 ± 0.9 | 12.2 ± 5.2 | 0.04* | |
RI | − 0.6 ± 0.01 | 0.7 ± 0.32 | 0.04* | |
LN mets | Early SUV | 4.5 ± 1.0 | 4.7 ± 3.2 | 0.30 |
Late SUV | 2.7 ± 1.01 | 8.2 ± 5.7 | < 0.001* | |
RI | − 0.45 ± 0.12 | 0.8 ± 0.3 | < 0.001* | |
Distant mets | Early SUV | 4.5 ± 1.6 | 5.7 ± 4.8 | 0.86 |
Late SUV | 2.9 ± 1.4 | 9.5 ± 7.7 | < 0.001* | |
RI | − 0.23 ± 0.7 | 0.7 ± 0.5 | 0.006* | |
Total lesions | Early SUV | 4.8 ± 1.6 | 5.2 ± 3.8 | 0.29 |
Late SUV | 2.8 ± 1.1 | 8.8 ± 6.2 | < 0.001* | |
RI | − 0.4 ± 0.5 | 0.8 ± 0.4 | < 0.001* | |
No. of RI | − ve | 15 (93.8%) | 5 (5.4%) | 0.001* |
+ ve | 1 (6.2%) | 87 (94.6%) |